LENZ THERAPEUTICS INC

23.98

07-October-24 14:59:38

15 minutes delayed

Stocks

-1.80

-6.98%

Today's range

23.88 - 26.17

ISIN

N/A

Source

NASDAQ

LENZ Therapeutics Announces Presentations at Upcoming Ophthalmology and Optometry Medical Conferences

30 Sep 2024 07:00:00 By Nasdaq GlobeNewswire
LENZ Therapeutics to Participate in Upcoming Investor Conferences

27 Aug 2024 15:01:00 By Nasdaq GlobeNewswire
LENZ Therapeutics Reports Second Quarter 2024 Financial Results

14 Aug 2024 15:05:00 By Nasdaq GlobeNewswire
LENZ Therapeutics Announces Submission of New Drug Application to U.S. Food and Drug Administration for LNZ100 for the Treatment of Presbyopia

12 Aug 2024 07:00:00 By Nasdaq GlobeNewswire
LENZ Therapeutics to Report Second Quarter 2024 Financial Results on August 14, 2024

07 Aug 2024 15:01:00 By Nasdaq GlobeNewswire
LENZ Therapeutics Announces $30 Million Investment from Ridgeback Capital

15 Jul 2024 07:00:00 By Nasdaq GlobeNewswire
LENZ Therapeutics to Host Key Opinion Leader Event on June 18, 2024

10 Jun 2024 07:00:00 By Nasdaq GlobeNewswire
LENZ Therapeutics to Present at the Jefferies Global Healthcare Conference

30 May 2024 07:00:00 By Nasdaq GlobeNewswire
LENZ Therapeutics Reports First Quarter 2024 Financial Results and Provides Business Updates

08 May 2024 15:01:00 By Nasdaq GlobeNewswire
LENZ Therapeutics to Report First Quarter Financial Results and Business Update on May 8, 2024

01 May 2024 15:01:00 By Nasdaq GlobeNewswire

<<
<
1
>

I Agree NetDania's website uses cookies. By continuing browsing our website, you agree to our Cookie Policy, Privacy Policy and Terms and Conditons.